Antimicrobial Agents and Chemotherapy, June 1999, p. 1469-1474, Vol. 43, No. 6
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
R. M. Alden Research Laboratory, Santa Monica-UCLA Medical Center, Santa Monica, California 90404,1 and UCLA School of Medicine, Los Angeles, California 900242
Received 23 October 1998/Returned for modification 21 February 1999/Accepted 14 March 1999
Linezolid was tested against 420 aerobes and anaerobes, including
148 Pasteurella isolates, by an agar dilution method.
Linezolid was active against all Pasteurella multocida
subsp. multocida and P. multocida subsp.
septica isolates and most Pasteurella canis,
Pasteurella dagmatis, and Pasteurella stomatis
isolates. The MIC was
2 µg/ml for staphylococci, streptococci,
EF-4b, Weeksella zoohelcum, Fusobacterium
nucleatum, other fusobacteria, Porphyromonas spp.,
Prevotella spp., peptostreptococci, and almost all
Bacteroides tectum isolates.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |